Department of Defense
INSTRUCTION
NUMBER 1010.16
October 10, 2012
Incorporating Change 1, Effective February 27, 2017
USD(P&R)
SUBJECT: Technical Procedures for the Military Personnel Drug Abuse Testing Program
(MPDATP)
References: See Enclosure 1
1. PURPOSE. This Instruction:
a. Pursuant to DoD Directive (DoDD) 5124.02 (Reference (a)) reissues DoD Instruction
(DoDI) 1010.16 (Reference (b)) to update the policies, requirements and procedures for the
MPDATP pursuant to DoDI 1010.01 (Reference (c)).
b. Incorporates and cancels Standard Operating Procedures Manual (Reference (d)).
c. Promotes standardization and joint service operations among all Service Forensic
Toxicology Drug Testing Laboratories (FTDTL).
2. APPLICABILITY. This Instruction:
a. Applies to:
(1) OSD, the Military Departments (including the Coast Guard when operating as a
service in the Navy), the Office of the Chairman of the Joint Chiefs of Staff and the Joint Staff,
the Combatant Commands, the Office of the Inspector General of the Department of Defense, the
Defense Agencies, the DoD Field Activities, and all other organizational entities within the DoD
(hereinafter referred to collectively as the “DoD Components”). The term “Military Services” as
used herein, refers to the Army, Navy, Air Force, Marine Corps, Active and Reserve
Components.
(2) Tests conducted under the MPDATP on specimens received by the military FTDTLs.
(3) Foreign nationals employed by DoD or attending U.S. military training schools only
as authorized by intergovernmental agreements negotiated on a country-by-country basis.
